HU0004994D0 - New 2,3-benzodiazepine derivatives and pharmaceutical compositions containing them - Google Patents

New 2,3-benzodiazepine derivatives and pharmaceutical compositions containing them

Info

Publication number
HU0004994D0
HU0004994D0 HU0004994A HUP0004994A HU0004994D0 HU 0004994 D0 HU0004994 D0 HU 0004994D0 HU 0004994 A HU0004994 A HU 0004994A HU P0004994 A HUP0004994 A HU P0004994A HU 0004994 D0 HU0004994 D0 HU 0004994D0
Authority
HU
Hungary
Prior art keywords
sup
sub
group
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0004994A
Other languages
English (en)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU0004994A priority Critical patent/HU225100B1/hu
Publication of HU0004994D0 publication Critical patent/HU0004994D0/hu
Priority to CZ20031680A priority patent/CZ301371B6/cs
Priority to EA200300691A priority patent/EA005867B1/ru
Priority to ES01271364T priority patent/ES2225412T3/es
Priority to AT01271364T priority patent/ATE271548T1/de
Priority to PL362029A priority patent/PL211495B1/pl
Priority to DE60104448T priority patent/DE60104448T2/de
Priority to PCT/HU2001/000151 priority patent/WO2002050044A1/en
Priority to UA2003076874A priority patent/UA74615C2/uk
Priority to JP2002551541A priority patent/JP4201252B2/ja
Priority to PT01271364T priority patent/PT1351942E/pt
Priority to ROA200300539A priority patent/RO121268B1/ro
Priority to AU2002217356A priority patent/AU2002217356A1/en
Priority to SK788-2003A priority patent/SK286620B6/sk
Priority to TR2004/02493T priority patent/TR200402493T4/xx
Priority to US10/450,898 priority patent/US7189711B2/en
Priority to DK01271364T priority patent/DK1351942T3/da
Priority to EP01271364A priority patent/EP1351942B1/en
Priority to CA2431761A priority patent/CA2431761C/en
Publication of HUP0004994A2 publication Critical patent/HUP0004994A2/hu
Priority to BG107932A priority patent/BG66199B1/bg
Publication of HU225100B1 publication Critical patent/HU225100B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HU0004994A 2000-12-21 2000-12-21 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk HU225100B1 (hu)

Priority Applications (20)

Application Number Priority Date Filing Date Title
HU0004994A HU225100B1 (hu) 2000-12-21 2000-12-21 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
CA2431761A CA2431761C (en) 2000-12-21 2001-12-19 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
PT01271364T PT1351942E (pt) 2000-12-21 2001-12-19 Novos derivados da 2,3-benzodiazepina e composicoes farmaceuticas contendo os mesmos como o ingrediente activo
AU2002217356A AU2002217356A1 (en) 2000-12-21 2001-12-19 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
ES01271364T ES2225412T3 (es) 2000-12-21 2001-12-19 Nuevos derivados de 2,3-benzodiazepina y composiciones farmaceuticas que contienen dichos derivados como principio activo.
AT01271364T ATE271548T1 (de) 2000-12-21 2001-12-19 ßNEUE 2,3-BENZODIAZEPINDERIVATE UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN, DIE DIESE VERBINDUNGEN ALS WIRKSTOFF ENTHALTENß
PL362029A PL211495B1 (pl) 2000-12-21 2001-12-19 Pochodne 2,3-benzodiazepiny, kompozycja farmaceutyczna zawierająca te pochodne jako składnik aktywny i ich zastosowanie
DE60104448T DE60104448T2 (de) 2000-12-21 2001-12-19 "neue 2,3-benzodiazepinderivate und pharmazeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten"
PCT/HU2001/000151 WO2002050044A1 (en) 2000-12-21 2001-12-19 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
UA2003076874A UA74615C2 (en) 2000-12-21 2001-12-19 2,3-benzodiazepine derivatives and pharmaceutical compositions containing these derivatives as active ingredient
JP2002551541A JP4201252B2 (ja) 2000-12-21 2001-12-19 新規な２，３−ベンゾジアゼピン誘導体及び該誘導体を有効成分として含有する医薬組成物
CZ20031680A CZ301371B6 (cs) 2000-12-21 2001-12-19 2,3-Benzodiazepinové deriváty, jejich použití a farmaceutické kompozice je obsahující
ROA200300539A RO121268B1 (ro) 2000-12-21 2001-12-19 Derivaţi de 2,3-benzodiazepină şi compoziţii farmaceutice care îi conţin ca ingredient activ
EA200300691A EA005867B1 (ru) 2000-12-21 2001-12-19 Производные 2,3-бензодиазепина и фармацевтические композиции, содержащие эти производные в качестве активного ингредиента
SK788-2003A SK286620B6 (sk) 2000-12-21 2001-12-19 2,3-Benzodiazepínové deriváty, ich použitie a farmaceutické kompozície s ich obsahom
TR2004/02493T TR200402493T4 (tr) 2000-12-21 2001-12-19 Yeni 2,3-benzodiazepin türevleri ve aktif bileşen olarak bunları içeren farmasötik bileşimler.
US10/450,898 US7189711B2 (en) 2000-12-21 2001-12-19 2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
DK01271364T DK1351942T3 (da) 2000-12-21 2001-12-19 Nye 2,3-benzodiazepinderivater og farmaceutiske sammensætninger indeholdende disse som den aktive bestanddel
EP01271364A EP1351942B1 (en) 2000-12-21 2001-12-19 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
BG107932A BG66199B1 (bg) 2000-12-21 2003-06-20 2,3-беhзодиазепинови производни и фармацевтични състави, които ги съдържат като активен компонент

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0004994A HU225100B1 (hu) 2000-12-21 2000-12-21 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk

Publications (3)

Publication Number Publication Date
HU0004994D0 true HU0004994D0 (en) 2001-03-28
HUP0004994A2 HUP0004994A2 (hu) 2002-11-28
HU225100B1 HU225100B1 (hu) 2006-06-28

Family

ID=89978876

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004994A HU225100B1 (hu) 2000-12-21 2000-12-21 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk

Country Status (20)

Country Link
US (1) US7189711B2 (hu)
EP (1) EP1351942B1 (hu)
JP (1) JP4201252B2 (hu)
AT (1) ATE271548T1 (hu)
AU (1) AU2002217356A1 (hu)
BG (1) BG66199B1 (hu)
CA (1) CA2431761C (hu)
CZ (1) CZ301371B6 (hu)
DE (1) DE60104448T2 (hu)
DK (1) DK1351942T3 (hu)
EA (1) EA005867B1 (hu)
ES (1) ES2225412T3 (hu)
HU (1) HU225100B1 (hu)
PL (1) PL211495B1 (hu)
PT (1) PT1351942E (hu)
RO (1) RO121268B1 (hu)
SK (1) SK286620B6 (hu)
TR (1) TR200402493T4 (hu)
UA (1) UA74615C2 (hu)
WO (1) WO2002050044A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302449A3 (en) * 2003-08-04 2005-06-28 Egis Gyogyszergyar Nyilvanosan 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them
CA2633804A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
MX2015001880A (es) * 2012-08-16 2015-05-11 Bayer Pharma AG 2,3-benzodiacepinas.
CA2915419A1 (en) * 2013-06-17 2014-12-24 Bayer Pharma Aktiengesellschaft Substituted phenyl-2,3-benzodiazepines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
DE19604920A1 (de) 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
RU2325811C2 (ru) 2006-06-28 2008-06-10 Общество С Ограниченной Ответственностью "Фито-Маг" Способ хранения плодоовощной и растениеводческой продукции

Also Published As

Publication number Publication date
US7189711B2 (en) 2007-03-13
ES2225412T3 (es) 2005-03-16
UA74615C2 (en) 2006-01-16
BG107932A (bg) 2004-02-27
CA2431761A1 (en) 2002-06-27
PL211495B1 (pl) 2012-05-31
BG66199B1 (bg) 2012-01-31
US20040092510A1 (en) 2004-05-13
CZ301371B6 (cs) 2010-02-03
TR200402493T4 (tr) 2004-12-21
JP2004516284A (ja) 2004-06-03
DK1351942T3 (da) 2004-11-22
HU225100B1 (hu) 2006-06-28
WO2002050044A1 (en) 2002-06-27
EP1351942B1 (en) 2004-07-21
EA005867B1 (ru) 2005-06-30
EP1351942A1 (en) 2003-10-15
RO121268B1 (ro) 2007-02-28
AU2002217356A1 (en) 2002-07-01
DE60104448D1 (de) 2004-08-26
PL362029A1 (en) 2004-10-18
DE60104448T2 (de) 2005-07-28
SK7882003A3 (en) 2003-11-04
HUP0004994A2 (hu) 2002-11-28
SK286620B6 (sk) 2009-02-05
EA200300691A1 (ru) 2003-12-25
PT1351942E (pt) 2004-11-30
JP4201252B2 (ja) 2008-12-24
CZ20031680A3 (cs) 2003-11-12
ATE271548T1 (de) 2004-08-15
CA2431761C (en) 2010-05-25

Similar Documents

Publication Publication Date Title
WO2001009103A3 (en) Imidazole antiproliferative agents
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
KR20050085991A (en) Compounds exhibiting thrombopoietin receptor agonism
CA2238430A1 (en) Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
TW283624B (hu)
MXPA04006322A (es) Derivados de 6-fluorobiciclo[3.1.0]hexano.
EP1207155A4 (en) DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY
GB9905075D0 (en) Chemical compounds
GB0013737D0 (en) Novel compounds
EP0765865A4 (en) 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION
DE60117847D1 (de) Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
IL154964A0 (en) Benzsulfonamide derivatives, their preparation and pharmaceutical compositions containing them
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
HK1052697A1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same.
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
AU1366802A (en) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
HU0004994D0 (en) New 2,3-benzodiazepine derivatives and pharmaceutical compositions containing them
HK1053109A1 (en) Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions comprising the same, methods for preparing them and the use for the preparation of a medicament of them
WO2001051004A3 (en) Anti-cancer agent containing naphthoquinone compound
IL110040A (en) Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
WO2000024389A3 (en) Benzoquinoline derivatives useful as antibacterial agents
AU2002214056A1 (en) Farnesyl transferase inhibiting benzoheterocyclic derivatives
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
WO2003027077A1 (fr) Derives de phenylpyridazine solubles dans l'eau et medicaments contenant ceux-ci

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYRT., HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

MM4A Lapse of definitive patent protection due to non-payment of fees